TOMI Environmental Solutions Secures SteraMist Implementation at New Cell and Gene Therapy Facility

Reuters
2025/12/23
<a href="https://laohu8.com/S/TOMZ">TOMI Environmental</a> Solutions Secures SteraMist Implementation at New Cell and Gene Therapy Facility

TOMI Environmental Solutions Inc. announced that a leading Cell and Gene Therapy (CGT) manufacturer has adopted its SteraMist ionized Hydrogen Peroxide (iHP) technology at a new commercial-scale pharmaceutical manufacturing facility. The implementation includes multiple SteraMist systems for surface treatment and automated room fogging, as well as TOMI’s standard operating procedure development package and an Installation and Operational Qualification package. The company’s iHP Corporate Service team will also perform comprehensive whole-facility fogging services for the client.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TOMI Environmental Solutions Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9616204) on December 22, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10